NCT00403793View on ClinicalTrials.gov

Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)

PHASE2CompletedINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Contraception

Interventions

DRUG

etonogestrel with testosterone undecanoate

42 or 44 weeks with etonogestrel implant and testosterone undecanoate injections every 10 to 12 weeks

DRUG

Placebo

42 or 44 weeks with placebo implant and placebo injections

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Organon and Co

INDUSTRY